PAPER Fleming JL, Phiel CJ, Toland AE
SEARCH RESULTS
331209 RESULTS
PAPER Huang Y, Zheng L, Halliday G, Dobson-Stone C, Wang Y, Tang HD, Cao L, Deng YL, Wang G, Zhang YM, Wang JH, Hallupp M, Kwok J, Chen SD
Genetic polymorphisms in sigma-1 receptor and apolipoprotein e interact to influence the severity of Alzheimer's disease.
Curr Alzheimer Res. 2011 Nov 1;8(7):765-70. PubMed: 21605063PAPER Woolley JD, Strobl EV, Shelly WB, Miller BL, Mellon SH, Rankin KP
BDNF Serum Concentrations Show No Relationship with Diagnostic Group or Medication Status in Neurodegenerative Disease.
Curr Alzheimer Res. 2011 May 24; PubMed: 21605064PAPER Figueroa RA, Ramberg V, Gatsinzi T, Samuelsson M, Zhang M, Iverfeldt K, Hallberg E
Anchored FRET sensors detect local caspase activation prior to neuronal degeneration.
Mol Neurodegener. 2011;6(1):35. PubMed: 21605370PAPER Pifferi F, Tremblay S, Croteau E, Fortier M, Tremblay-Mercier J, Lecomte R, Cunnane SC
Mild experimental ketosis increases brain uptake of 11C-acetoacetate and 18F-fluorodeoxyglucose: a dual-tracer PET imaging study in rats.
Nutr Neurosci. 2011 Mar;14(2):51-8. PubMed: 21605500PAPER Last NB, Rhoades E, Miranker AD
Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity.
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9460-5. PubMed: 21606325PAPER Schipke CG, Jessen F, Teipel S, Luckhaus C, Wiltfang J, Esselmann H, Frölich L, Maier W, Rüther E, Heppner FL, Prokop S, Heuser I, Peters O
Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid.
J Alzheimers Dis. 2011;26(2):255-62. PubMed: 21606567PAPER Scarpini E, Bruno G, Zappalà G, Adami M, Richarz U, Gaudig M, Jacobs A, Schäuble B
Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.
J Alzheimers Dis. 2011;26(2):211-20. PubMed: 21606568PAPER Koch G, Esposito Z, Kusayanagi H, Monteleone F, Codecá C, Di Lorenzo F, Caltagirone C, Bernardi G, Martorana A
CSF tau levels influence cortical plasticity in Alzheimer's disease patients.
J Alzheimers Dis. 2011;26(1):181-6. PubMed: 21606570PAPER Alexopoulos P, Richter-Schmidinger T, Horn M, Maus S, Reichel M, Sidiropoulos C, Rhein C, Lewczuk P, Doerfler A, Kornhuber J
Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.
J Alzheimers Dis. 2011;26(2):207-10. PubMed: 21606569PAPER Franceschi M, Caffarra P, Savarè R, Cerutti R, Grossi E,
Tower of London test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer's disease.
Behav Neurol. 2011 Jan 1;24(2):149-58. PubMed: 21606576PAPER Hashimoto M, Hossain S
Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.
J Pharmacol Sci. 2011;116(2):150-62. PubMed: 21606627PAPER Buchman AS, Boyle PA, Leurgans SE, Barnes LL, Bennett DA
Cognitive function is associated with the development of mobility impairments in community-dwelling elders.
Am J Geriatr Psychiatry. 2011 Jun;19(6):571-80. PubMed: 21606900PAPER Saraf MK, Prabhakar S, Khanduja KL, Anand A
Bacopa monniera Attenuates Scopolamine-Induced Impairment of Spatial Memory in Mice.
Evid Based Complement Alternat Med. 2011;2011:236186. PubMed: 21607013PAPER Sodhi RK, Singh N, Jaggi AS
Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.
Naunyn Schmiedebergs Arch Pharmacol. 2011 Aug;384(2):115-24. PubMed: 21607645Current Filters
No filters selected